Working to provide information, support and access to established, new or innovative treatments for Atrial Fibrillation (AF)
October medical e-News 2018
Here is your latest edition of the monthly e-news.
The World Stroke Congress 2018 is hosting a symposium with a panel of experts to discuss Atrial Fibrillation and various ways to advance policies and advocacy initiatives that can help reduce the risk of AF-related stroke.
Our very own Trudie Lobaan will be presenting - Read more to tune in tomorrow at 13:00h EST - 18:00h BST.
Making promises for all our hearts
World Heart Day is the world’s biggest awareness-raising platform for cardiovascular disease. The annual campaign brings together individuals, families, communities and organisations around the world to participate in activities to take charge of their heart health and that of others. This year’s theme for World Heart Day is to make a promise... for my heart, for your heart, for all our hearts.
We’re supporting the Cardiovascular Health campaign with Media Planet UK
A Mother’s Mission to Educate the World About Arrhythmia
When Trudie Lobban’s daughter Francesca, now 29, was a baby, the girl had fainting episodes up to eight times a day. It took three years until Francesca was diagnosed with Reflex Anoxic Seizures (RAS), a condition that caused her heart to briefly stop.
Should We Switch Patients Who Appear to Be Optimally Anticoagulated on Warfarin to DOACs?*
wo different types of oral anticoagulants (OACs) are currently available to reduce the risk of stroke/systemic embolism (SE) in patients with atrial fibrillation (AF): vitamin K antagonists (VKAs) and direct OACs (DOACs) (1).
Stroke prevention in Europe: how are 11 European countries progressing toward the European Society of Cardiology (ESC) recommendations?
Stroke is a leading cause of death and disability, although studies show that 90% of strokes can be prevented.